Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the page.SummaryDifference0.0%

- Check24 days agoChange DetectedEditorial refinements were made to the Publications section to clarify that some publications are entered voluntarily and that others are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page removed a government funding/operational status notice related to NIH operations; this change does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedAdded the Study Results section with linked publications and updated results dates, including the NEJM 2024 publication.SummaryDifference0.2%

- Check75 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.